Axogen Inc

Healthcare · Medical Devices

37.40$ -6.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Axogen Inc (AXGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 305 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AXGN
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	31	46	43	43	42	59	55	161	162	160	160	157	154	155	145	170	194	201	197	211	210	208	198	196	196	195	189	192	195	197	187	189	192	204	196	205	216	222	289	305
Current Assets	29	44	41	40	40	56	52	157	153	151	146	141	137	135	120	140	140	145	135	142	135	127	112	107	102	98	89	86	87	88	79	82	86	99	93	103	114	120	185	200
Cash	16	30	26	24	22	37	31	134	26	24	24	25	25	36	36	75	60	49	40	53	47	33	15	12	14	15	14	23	37	31	16	19	19	28	18	26	24	36	83	95
Cash & Short-Term Investments	16	30	26	24	22	37	31	134	126	117	108	103	100	97	83	99	99	104	91	100	92	84	67	58	53	49	44	35	39	31	18	21	25	33	22	36	36	36	83	95
Receivables	7.0	8.1	8.4	9.4	10	11	12	12	14	15	15	16	16	17	13	14	19	18	20	19	19	18	19	20	21	22	22	22	23	25	24	25	25	24	26	28	31	26	28	34
Inventory	5.0	5.5	5.9	6.3	6.7	7.3	8.1	9.7	11	12	13	14	14	14	15	13	12	13	13	13	15	17	17	19	19	19	20	21	23	23	28	28	29	33	36	37	41	42	46	47
Property, Plant & Equipment	1.3	1.5	1.5	1.6	1.8	2.2	2.4	2.5	7.7	8.0	9.2	9.8	12	18	20	25	36	38	44	66	56	78	82	86	90	94	–	101	103	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.8	0.8	0.9	0.9	1.0	0.9	1.1	1.2	1.2	1.2	1.2	1.4	1.5	1.5	1.6	1.7	1.8	2.1	2.3	2.5	2.7	2.9	3.2	3.3	3.4	3.6	3.9	4.0	4.3	4.5	4.8	5.0	5.2	5.6	5.9	6.1	6.4	6.8	7.3	7.6
Total Liabilities	30	31	31	31	32	34	33	10	12	13	20	19	19	22	21	50	72	78	78	92	95	95	94	94	94	94	92	94	97	101	93	93	93	100	91	93	96	93	45	49
Current Liabilities	4.6	11	11	11	11	14	16	9.9	12	13	16	16	17	21	19	14	19	23	22	22	23	24	23	24	24	24	21	24	27	30	23	23	23	31	22	25	28	24	26	30
Short-Term Debt	4.0	4.0	4.0	3.9	4.0	6.9	6.8	0.0	0.0	0.0	1.4	1.8	1.8	1.7	1.8	1.6	2.5	0.9	1.4	1.8	1.7	1.8	2.1	1.8	1.5	1.3	1.1	1.0	1.1	1.5	1.6	1.8	1.9	2.0	2.1	2.2	2.3	2.4	2.1	2.0
Accounts Payable	1.9	3.6	2.9	3.1	2.1	3.2	3.3	4.2	4.8	4.5	7.4	5.7	3.8	8.3	7.2	3.9	3.5	4.6	9.2	6.7	6.4	5.9	21	22	22	9.0	20	23	26	12	21	22	21	8.0	20	23	26	2.9	24	28
Long-Term Debt	25	20	20	20	20	20	18	0.0	0.0	0.0	3.2	2.4	2.0	1.6	1.2	32	51	53	53	46	46	66	45	45	45	66	46	46	46	47	47	47	47	47	48	48	48	48	–	–
Shareholders' Equity	1.1	15	12	11	11	25	22	151	149	147	141	138	135	132	124	120	122	123	120	119	115	113	104	102	101	101	98	97	98	96	93	96	99	104	105	112	121	129	245	256
Retained Earnings	-112	-118	-122	-124	-126	-128	-134	-141	-145	-151	-160	-167	-173	-180	-188	-196	-198	-204	-210	-218	-225	-231	-242	-250	-254	-260	-267	-273	-277	-281	-288	-290	-292	-291	-295	-295	-294	-307	-327	-328
Shares Outstanding	30	33	33	33	33	34	35	37	39	39	39	39	39	39	40	40	40	40	41	41	41	41	42	42	42	42	43	43	43	43	43	44	44	48	45	46	46	47	52	53

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings